The post Strike Bitlicense marks NY bitcoin custody, lending rollout appeared on BitcoinEthereumNews.com. New York has approved a major step for bitcoin financialThe post Strike Bitlicense marks NY bitcoin custody, lending rollout appeared on BitcoinEthereumNews.com. New York has approved a major step for bitcoin financial

Strike Bitlicense marks NY bitcoin custody, lending rollout

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

New York has approved a major step for bitcoin financial services as the state grants the long-sought strike bitlicense to a fast-growing crypto firm.

Regulatory green light from New York

Strike has secured both a BitLicense and a money transmitter license from the New York State Department of Financial Services (NYDFS), allowing the company to operate in one of the United States’ most tightly regulated digital asset markets.

With this approval, the firm can now offer New York individuals and businesses a full suite of bitcoin-related services. These include buying and selling bitcoin, converting paychecks into bitcoin, and paying recurring bills such as utilities, credit cards and mortgages directly from bitcoin balances across the state.

Moreover, the authorization allows Strike to provide custody, trading and bill-pay services throughout New York. That said, the company remains bound by NYDFS compliance standards, which are among the strictest in the digital assets sector.

Services for retail and business users

Strike plans to roll out tools such as recurring purchases and price-triggered orders that execute trades automatically once the bitcoin price reaches a pre-set level. In addition, New York users will be able to convert up to 100% of their direct-deposited wages into bitcoin, with conversion fees waived on deposits up to $20,000 each month.

However, the firm emphasizes that customer bitcoin and cash balances are held on a one-to-one basis. Strike states that these balances are not lent out, nor are they used to fund company operations, positioning the platform as a conservative custodian after previous market turmoil.

Strategy and leadership vision

“Receiving our BitLicense is a defining milestone for Strike,” said Jack Mallers, the company’s founder and chief executive. “With our BitLicense, we can now bring that mission to New York, the global center of finance,” he added, underscoring the importance of the approval.

Furthermore, Strategy’s entrance into New York forms part of a broader expansion roadmap. The company is preparing to introduce bitcoin-backed lending, allowing users to borrow fiat currency while continuing to hold their bitcoin, a structure that aims to avoid forced asset sales.

Expansion into a risky lending segment

The planned lending products would let customers access traditional currency while maintaining exposure to bitcoin price movements. However, this move pushes Strike into a market segment that suffered several high-profile failures in 2022, when lenders such as BlockFi, Celsius and Genesis filed for bankruptcy.

That said, the firm presents its approach as more conservative than some failed competitors. By holding customer assets one-to-one and avoiding rehypothecation, Strike is seeking to reassure regulators and users wary of leverage and opaque balance sheets in crypto lending.

Regulatory oversight and compliance

The strike bitlicense places the company directly under NYDFS supervision. This oversight includes formal audits, capital reserve requirements and regular cybersecurity examinations intended to reduce operational and systemic risks.

Moreover, the New York approval signals a notable vote of confidence in Strike’s compliance framework. For the NYDFS, it also demonstrates that new entrants in bitcoin bill-pay and trading can still meet stringent standards imposed after earlier industry crises.

Implications for the New York bitcoin market

Industry observers note that Strategy’s New York BitLicense approval could intensify competition among platforms offering services to residents and businesses in the state. With tools to buy and sell bitcoin, convert wages, and pay bills in one interface, Strike is positioning itself as a full-stack provider.

In addition, the ability to convert a paycheck to bitcoin and access future lending products may appeal to users looking for integrated bitcoin financial services in New York. However, the long-term impact will depend on user adoption, market conditions and the platform’s capacity to maintain regulatory trust.

In summary, Strike’s licensing by NYDFS opens the door to expanded bitcoin custody, trading and bill-pay offerings in New York while setting the stage for future lending products in a closely watched regulatory environment.

Source: https://en.cryptonomist.ch/2026/03/06/strike-bitlicense-ny-expansion/

Market Opportunity
Major Logo
Major Price(MAJOR)
$0.06076
$0.06076$0.06076
+1.24%
USD
Major (MAJOR) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09